China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (02005.HK): Procured the drug production registration approval for the sustained-release capsule of nonophenolic acid choline (135mg).

Zhixin Financial News APP News, Shisiyao Group (02005.HK) has announced that the group has obtained the drug production registration certificate for the norebetaine acid choline sustained-release capsule (135mg) from the China National Medical Products Administration. It belongs to the fourth category of chemical drugs and is considered to have passed the consistency evaluation.